Editors’ Picks, June 2024: Metabolic Imaging, Practice-changing Adagrasib Trial, and More
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
A special issue of Cancer Discovery illustrates the vast landscape of research being explored within the AACR community.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
AACR will host the inaugural Blood Cancer Discovery Symposium March 4-6, 2024, featuring experts from all areas of blood...
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...